|
03 Jan 2008 |
Acambis reports positive data from trials of universal influenza A vaccine
|
|
31 Dec 2007 |
IDM Pharma Announces Termination of UVIDEM Development Collaboration and Expected Restructuring in Connection With Evaluation of Strategic Alternatives
|
|
27 Dec 2007 |
Northwest Biotherapeutics Conducting Ovarian Cancer Clinical Trial With DCVax(R)-L at University of Pennsylvania
|
|
24 Dec 2007 |
Sinovac Reports Top-Line Preliminary Phase II Results of Pandemic Influenza (H5N1) Whole Viron Vaccine
|
|
21 Dec 2007 |
Curalogic announces top line results from Phase III clinical study with the
|
|
21 Dec 2007 |
Aeras and Crucell Announce Start of a Tuberculosis Vaccine Clinical Trial in the United States. Aeras commits a further USD 5 million to the development of the tuberculosis vaccine
|
|
20 Dec 2007 |
Successful Collaboration between US Army and Intercell Towards a Novel Vaccine Against JE
|
|
20 Dec 2007 |
Novavax Announces Favorable Interim Results From Human Clinical Trial
|
|
20 Dec 2007 |
Genitope Corporation Reports Initial Results of Phase 3 Clinical Trial of MyVax(R) Personalized Immunotherapy
|
|
19 Dec 2007 |
GlobeImmune Announces Initiation of Phase II Clinical Trial of GI-5005 in Patients with Chronic Hepatitis C
|
|
17 Dec 2007 |
Lilly and BioMS Medical Announce Global Licensing and Development Agreement
|
|
17 Dec 2007 |
GlaxoSmithKline receives FDA 'complete response' letter for cervical cancer vaccine
|
|
16 Dec 2007 |
Intercell receives Milestone Payment from Merck & Co. Inc.
|
|
14 Dec 2007 |
IDM Pharma Provides Update of Product Pipeline and Announces Plans to Evaluate Strategic Alternatives for the Company
|
|
12 Dec 2007 |
Geron receives milestone payment from merck triggered by ind filing for telomerase cancer vaccine candidate
|
|
10 Dec 2007 |
Oxford Biomedica Announces Data Safety Monitoring Board Recommendation to ContinueTroVax(R) Phase III Trial in Renal Cancer
|
|
07 Dec 2007 |
Intercell Submits Marketing Authorization Application (MAA) to EMEA for Licensure of Japanese Enceph
|
|
06 Dec 2007 |
AVANT Immunotherapeutics Achieves Immune Responses Against Cholera, Typhoid and Enterotoxigenic E. coli with a Single-Dose, Oral Combination Vaccine
|
|
06 Dec 2007 |
Nventa completes enrollment and initial dosing of second cohort in phase 1 hspE7 safety trial
|
|
04 Dec 2007 |
SSI, Intercell and Aeras announce start of clinical trial for novel vaccine candidate against TB
|
|
29 Nov 2007 |
Bavarian Nordic A/S reports positive data from first EUA enabling study with IMVAMUNE(R) smallpox vaccine
|
|
29 Nov 2007 |
Cytos Biotechnology announces start of two phase II studies
|
|
28 Nov 2007 |
Oralair(R) Grasses: Positive results of VO52.06 paediatric study
|
|
27 Nov 2007 |
Nventa updates progress with new HspE7 in Phase 1 trial in cervical dysplasia
|
|
27 Nov 2007 |
Inovio Biomedical Partner Tripep Treats First Subject in Phase I/II Study of Novel Hepatitis C DNA Vaccine
|
